Barrons
News Agency

This Medtech Beat Earnings Estimates. It's the Worst S&P 500 Stock Today.
Insulet lowers its full-year revenue growth outlook, even after earnings and revenue handily beat expectations.
Related Symbols
1
I
IVV
IVV
Source:
Barrons
Visit Source
Comments